185 related articles for article (PubMed ID: 17602759)
1. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Tamaño-Blanco M; Abdelrahman N; Badgett D; Durfee J; Hussein S; Feichter J; Patrick K; Benedict R; Ramanathan M
J Neuroimmunol; 2007 Aug; 188(1-2):167-74. PubMed ID: 17602759
[TBL] [Abstract][Full Text] [Related]
2. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
[TBL] [Abstract][Full Text] [Related]
3. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
Azoulay D; Urshansky N; Karni A
J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
[TBL] [Abstract][Full Text] [Related]
4. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
5. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
6. No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis.
Blanco Y; Gómez-Choco M; Arostegui JL; Casanova B; Martínez-Rodríguez JE; Boscá I; Munteis E; Yagüe J; Graus F; Saiz A
Neurosci Lett; 2006 Apr; 396(3):217-9. PubMed ID: 16356643
[TBL] [Abstract][Full Text] [Related]
7. Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI.
Benedetti B; Charil A; Rovaris M; Judica E; Valsasina P; Sormani MP; Filippi M
Neurology; 2006 Feb; 66(4):535-9. PubMed ID: 16505308
[TBL] [Abstract][Full Text] [Related]
8. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
[TBL] [Abstract][Full Text] [Related]
9. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression.
Taylor WD; Züchner S; McQuoid DR; Payne ME; MacFall JR; Steffens DC; Speer MC; Krishnan KR
Am J Geriatr Psychiatry; 2008 Apr; 16(4):263-71. PubMed ID: 18263664
[TBL] [Abstract][Full Text] [Related]
10. Evolution of brain-derived neurotrophic factor levels after autologous hematopietic stem cell transplantation in multiple sclerosis.
Blanco Y; Saiz A; Costa M; Torres-Peraza JF; Carreras E; Alberch J; Jaraquemada D; Graus F
Neurosci Lett; 2005 May 20-27; 380(1-2):122-6. PubMed ID: 15854763
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A
Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
[TBL] [Abstract][Full Text] [Related]
12. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
[TBL] [Abstract][Full Text] [Related]
13. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.
Sharma J; Zivadinov R; Jaisani Z; Fabiano AJ; Singh B; Horsfield MA; Bakshi R
J Neuroimaging; 2006 Oct; 16(4):302-10. PubMed ID: 17032378
[TBL] [Abstract][Full Text] [Related]
14. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
15. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
[TBL] [Abstract][Full Text] [Related]
16. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
[TBL] [Abstract][Full Text] [Related]
17. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
[TBL] [Abstract][Full Text] [Related]
18. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
Zivadinov R; Locatelli L; Cookfair D; Srinivasaraghavan B; Bertolotto A; Ukmar M; Bratina A; Maggiore C; Bosco A; Grop A; Catalan M; Zorzon M
Mult Scler; 2007 May; 13(4):490-501. PubMed ID: 17463072
[TBL] [Abstract][Full Text] [Related]
19. [Value of magnetization transfer imaging in judging microchanges lesions in normal-appearing white matter of multiple sclerosis].
Chu SG; Shen TZ; Chen XR
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1181-5. PubMed ID: 15387980
[TBL] [Abstract][Full Text] [Related]
20. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
Agosta F; Rovaris M; Pagani E; Sormani MP; Comi G; Filippi M
Brain; 2006 Oct; 129(Pt 10):2620-7. PubMed ID: 16951409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
